Antiphospholipid Syndrome

Top Story

Triple-therapy regimen associated with improved survival in catastrophic antiphospholipid syndrome

June 16, 2017

MADRID — A triple regimen of anticoagulation therapy, corticosteroids and plasma exchange and/or immunoglobulins was associated with reduced mortality among patients with catastrophic antiphospholipid syndrome, according to findings presented at the EULAR Annual Congress.

“Triple therapy showed to be independently associated to a higher survival rate in [catastrophic antiphospholipid syndrome] CAPS,” Ignasi Rodriguez-Pinto, MD, of the Department of Autoimmune Disease at the Hospital Clinic at Barcelona University in Spain, said.

In the JournalsPerspective

EULAR publishes recommendations for women with lupus

March 9, 2017
A team of EULAR researchers published recommendations for health issues and family planning for women with lupus or antiphospholipid syndrome. Laura Andreoli
Meeting News Coverage

Lupus anticoagulant associated with risks in patients with aPL antibodies

December 15, 2015
Most events related to antiphospholipid-positivity were not associated with the antiphospholipid antibody profile, however, an association was observed between the risk…
Meeting News Coverage

Upcoming ACR conference highlights advances in all fields in rheumatology

November 5, 2015
The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many topics — ranging…
CME

Timing of Tourniquet Release in Total Knee Arthroplasty: July 2015

The authors conducted a meta-analysis to determine the optimal tourniquet application strategy in total knee…
More »
Video
Meeting News

VIDEO: Lohmander calls for individualized exercise therapy for patients with OA

May 15, 2017
More »
Resource Centers
EULAR Annual Congress

EULAR Annual Congress

CME

Protocol-Based Arthroplasty: Less Is More: October 2015

Total joint arthroplasty is a successful orthopedic procedure that is performed in high volume in the United States and…
More »
Meeting News

Triple-therapy regimen associated with improved survival in catastrophic antiphospholipid syndrome

June 16, 2017
MADRID — A triple regimen of anticoagulation therapy, corticosteroids and plasma exchange and/or immunoglobulins was associated with reduced…

In the JournalsPerspective

EULAR publishes recommendations for women with lupus

March 9, 2017
A team of EULAR researchers published recommendations for health issues and family planning for women with lupus or antiphospholipid syndrome. …

Meeting News Coverage

Lupus anticoagulant associated with risks in patients with aPL antibodies

December 15, 2015
Most events related to antiphospholipid-positivity were not associated with the antiphospholipid antibody profile, however, an association was…

Meeting News Coverage

Upcoming ACR conference highlights advances in all fields in rheumatology

November 5, 2015
The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many…

Stay Current With Our Peer-Tested Content

Healio Rheumatology, Premier Issue
Welcome to the Premier Issue of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of…

Eight articles focus on pregnancy challenges for patients with rheumatic diseases

October 16, 2015
Challenges to successful pregnancy outcomes arise for some patients with rheumatic diseases, including systemic lupus erythematosus, rheumatoid…

In the Journals

Pregnant women with aPL antibodies may benefit from hydroxychloroquine

October 15, 2015
Women with antiphospholipid syndrome or positive antiphospholipid antibodies who became pregnant while receiving hydroxychloroquine for at least 6…

SLACK Incorporated launches Healio Rheumatology

October 1, 2015
SLACK Incorporated, publisher of Healio.com, is set to expand its series of web-first news magazines delivering unique peer-tested content. Healio

In the Journals

Increased levels of factor H antibodies present in patients with APS, recurrent thrombosis

August 26, 2015
Patients with antiphospholipid syndrome who had recurring venous thrombosis had increased levels of autoantibodies to factor H, according to recently…

Meeting News Coverage

Patients with antiphospholipid syndrome may benefit from Soliris

August 19, 2015
Patients with antiphospholipid syndrome had higher platelet counts after treatment with Soliris, according to the results of a preliminary study…

More Headlines »
Advertisement
Advertisement